Residual fetal cells in women may provide protection against breast cancer

	Tweet

Fetal cells that persist in a woman’s body long after pregnancy – a common occurrence known in scientific circles as fetal microchimerism – in some cases may reduce the woman’s risk of breast cancer, according to researchers at Fred Hutchinson Cancer Research Center. The findings, published in the Oct. 1 issue of Cancer Research, add to the Jekyll and Hyde characteristics of fetal microchimerism, or FMc, which has been found to be both detrimental and beneficial to women’s health.

In this latest prospective study, scientists V.K. Gadi, M.D., Ph.D. and J. Lee Nelson, M.D., examined the blood of 82 women post-pregnancy, 35 of whom had had breast cancer. They looked for male DNA in the blood, presuming it was present due to a prior pregnancy.

. Fetal microchimerism (FMc) was found significantly more often in healthy women than women with a history of breast cancer, 43 percent versus 14 percent respectively. The scientists concluded that FMc may contribute to reduction of breast cancer based on the hypothesis that residual fetal cells may provide immune surveillance of malignant cells in the mother. They caution that further studies are needed to confirm the theory.

“To our knowledge, the current results provide the first indication that FMc could impart a protective effect against breast cancer,” Gadi said.

Prior research into FMc, some of it performed at the Hutchinson Center, indicates that while the presence of fetal cells in women may confer immune protection and promote cell repair, such cells also may be harbingers of some autoimmune diseases.

Two observations provided a rationale for the study hypothesis of the potential beneficial role of fetal cells, according to the authors. It is well established that women who have given birth have a lower risk of breast cancer. And, allogeneic (from another individual) stem-cell transplants are used to treat many types of blood cancers by replacing a diseased immune system with a healthy one

Additionally, fetal cells are commonly found in the circulating blood of healthy women who have given birth. Fetal cells represent a naturally acquired source of allogeneic immune cells; in prior studies the prevalence of T, B, natural-killer (NK) and antigen-presenting cells of fetal origin in healthy women ranged from 30 percent to 70 percent, depending on the cell type. The research was funded by the National Institutes of Health and Amgen Inc.

###

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

Contact: Dean Forbes

206-667-2896
Fred Hutchinson Cancer Research Center

RELATED STORIES:
GW researchers reveal digital transcriptome of breast cancer   Metabolic Factors May Play a Role in Risk for Breast Cancer   Breast Cancer in Black Women May be Connected to Neighborhoods   Researchers Look for Obesity and Breast Cancer Link   Alcohol may raise chances of breast cancer return   The ‘2-week wait rule’ is failing breast cancer patients   AACR to Honor Leading Researchers at Breast Cancer Symposium   Study helps eliminate causes for joint pain linked to commonly used breast cancer drugs   How women can improve their quality of life after breast cancer treatment   Wet ear wax and unpleasant body odors signal breast cancer risk   Fish Oil May Reduce Risk of Breast Cancer   Tamoxifen Chemoprevention Tied to Early Detection of Breast Cancer   Late treatment with letrozole can reduce breast cancer recurrence risk   Signs that bone drug may block breast tumors   Time to raise how many mammograms radiologists must read?   Radiation ups risk of breast cancer in young women   Breast cancer drug switch cuts deaths   EU agency reviews Roche’s Avastin in breast cancer   Tumor-free breast tissue can have precancerous changes   Breast cancer survivors struggle with cognitive problems several years after treatment   New Genetic Test for Personalized Treatment of Breast Cancer   Dieting reduces lymphedema after breast cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]